Skip to main content

Acconeer AB (publ) announces that the directed share issue to Alps Alpine of approximately SEK 25 million is completed

By

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, JAPAN, BELARUS, RUSSIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.

Acconeer AB’s (publ) (“Acconeer” or the “Company”) new share issue, comprising of 5,482,456 shares, directed to the strategic investor Alps Alpine Co., Ltd. (“Alps Alpine”), which, in accordance with the Board of Directors’ proposal on 14 February 2025, was resolved by the extraordinary general meeting on 6 March 2025 (the “Directed Share Issue”), has, in accordance with subscription agreement, been fully subscribed and allotted. Through the Directed Share Issue, the Company will receive approximately SEK 25 million before issue costs.

The Directed Share Issue

The extraordinary general meeting resolved on 6 March 2025, in accordance with the Board of Directors’ proposal, on a directed share issue of a maximum of 5,482,456 shares. The existing shareholder Alps Alpine was entitled to subscribe for the Directed Share Issue. The reason why the Directed Share Issue was directed to an existing shareholder is that the shareholder has expressed and shown a long-term interest in and commitment to the Company, which, according to the Board of Directors, creates security and stability for both the Company and its shareholders. Alps Alpine is a strategically important investor, and without Alps Alpine it would not have been possible for the Company to secure the financing of the A2 project, i.e the development of next-generation radar sensor, the A2, which will open up new, advanced applications and commercial opportunities.

All 5,482,456 shares in the Directed Share Issue have been subscribed for and allotted. The subscription price was set after arm's length negotiations between the Company and Alps Alpine at SEK 4.56 per share, which corresponds to the closing price of the Company’s share on 13 February 2025. Through the Directed Share Issue, the Company will raise approximately SEK 25 million before issue costs.

Rights issue (compensation issue)

As part of the agreement with Alps Alpine and to compensate the shareholders who did not participate in the Directed Share Issue, the extraordinary general meeting resolved, in accordance with the Board of Directors’ proposal, on a fully secured rights issue of a maximum of 5,484,249 shares which, upon full subscription, will provide the Company with approximately SEK 25 million before deduction of issue costs (the “Rights Issue” or the Compensation Issue”). One (1) existing share in the Company on the record date, 14 March 2025, entitles to three (3) subscription rights. Thirty-four (34) subscription rights entitle to subscription of one (1) new share. The subscription period in the Rights Issue runs from 18 March 2025 up to and including 1 April 2025.

For full terms and conditions of the Rights Issue as well as information about the Company, please refer to the information memorandum published by the Company on 14 March 2025, which is available on the Company's website www.acconeer.com.

Subscription forms and other relevant information will be available on the Company's website and Eminova Fondkommission AB's website www.eminova.se.

Timetable for the Rights Issue

18 March 2025 – 27 March 2025 Trading in subscription rights
18 March 2025 – 1 April 2025 Subscription period
18 March 2025 – 22 April 2025 Trading in paid subscribed shares (BTA)
3 April 2025 Estimated date of announcement of the outcome of the Rights Issue

Change in number of shares and share capital and dilution

Through the Directed Share Issue, the number of shares in Acconeer increases by 5,482,456 shares, from 62,154,827 shares to 67,637,283 shares, and the share capital increases by SEK 274,122.8, from SEK 3,107,741.35 to SEK 3,381,864.15, resulting in a dilution of approximately 8.1 per cent.

Through the Rights Issue, the number of shares in Acconeer will increase by a maximum of 5,484,249 shares, from 67,637,283 shares to 73,121,532 shares, and the share capital will increase by a maximum of SEK 274,212.45, from SEK 3,381,864.15 to SEK 3,656,076.60. For existing shareholders who do not participate in the Rights Issue, this means, at full subscription, an additional dilution effect of approximately 7.5 per cent of the votes and capital in the Company.

The total dilution effect, if both the Directed Share Issue and the Rights Issue are fully subscribed, amounts to approximately 15 per cent.

Advisors

Moll Wendén Advokatbyrå AB is legal advisor to the Company in connection with the Directed Share Issue and Eminova Fondkommission AB is issuing agent in connection with the Directed Share Issue.

The subscription period in Acconeer’s rights issue (compensation issue) begins today

By

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, JAPAN, BELARUS, RUSSIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.

Today, 18 March 2025, is the first day of the subscription period in Acconeer AB's (“Acconeer” or the “Company”) rights issue of share with preferential rights for existing shareholders (the “Rights Issue”) which was proposed by the Board of Directors on 14 February 2025 andapproved by the extraordinary general meeting held on 6 March 2025. Upon fullsubscription in the Rights Issue, the Company will initially receive approximately SEK 25 millionbefore deduction of issue costs.

Summary of the Rights Issue

  • One (1) existing share in the Company on the record date, 14 March 2025, entitles to three (3) subscription rights. Thirty-four (34) subscription rights entitle to subscription of one (1) new share.
  • The Rights Issue comprises a maximum of 5,484,249 new shares. Upon full subscription in the Rights Issue, Acconeer will receive approximately SEK 25 million before deduction of issue costs.
  • The subscription price in the Rights Issue is SEK 4.56 per share, which corresponds to the closing price of the Company's share on 13 February 2025.
  • The subscription period in the Rights Issue runs from and including 18 March 2025 up to and including 1 April 2025.
  • In order not to lose the value of the subscription rights, the holder must either sell the subscription rights received that are not intended to be utilized for subscription of shares no later than 27 March 2025, or exercise the received subscription rights and subscribe for new shares no later than 1 April 2025.
  • Prior to the Rights Issue, the Company has received subscription undertakings totalling approximately SEK 4.28 million, corresponding to approximately 17.12 per cent of the Rights Issue. In addition, the Company has received free of charge bottom guarantee undertakings amounting to approximately SEK 2.0 million, corresponding to approximately 8 per cent of the Rights Issue. In addition, the Company has also received free of charge top guarantee undertakings totalling approximately SEK 18.72 million, corresponding to approximately 74.88 per cent of the Rights Issue. In total, 100 per cent of the Rights Issue is covered by free of charge subscription undertakings and free of charge bottom and top guarantee commitments. Neither the subscription undertakings nor the bottom or top guarantee commitments are secured by bank guarantees, blocked funds, pledges or similar arrangements.

Information memorandum

For full terms and conditions of the Rights Issue as well as information about the Company, please refer to the information memorandum published by the Company on 14 March 2025, which is available on the Company's website www.acconeer.com.

Subscription forms and other relevant information will be available on the Company's website and Eminova Fondkommission AB's website www.eminova.se.

Timetable for the Rights Issue

18 March 2025 – 27 March 2025 Trading in subscription rights
18 March 2025 – 1 April 2025 Subscription period
18 March 2025 – 22 April 2025 Trading in paid subscribed shares (BTA)
3 April 2025 Estimated date of announcement of the outcome of the Rights Issue

Advisors

Moll Wendén Advokatbyrå AB is legal advisor to Acconeer AB in connection with the Rights Issue and Eminova Fondkommission AB is acting as issuing agent in connection with the Rights Issue.

Acconeer AB (publ) publishes information memorandum in connection with upcoming rights issue (compensation issue)

By

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, HONG KONG, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, SINGAPORE, JAPAN, BELARUS, RUSSIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.

The Board of Directors of Acconeer AB (publ) (”Acconeer” or the ”Company”) has, in connection with the rights issue of shares of approximately SEK 25 million proposed by the Board of Directors on 14 February 2025 and resolved by the extraordinary general meeting held on 6 March 2025 (the ”Rights Issue”), prepared an information memorandum (the ”Memorandum”). The Memorandum is available in Swedish on the Company's website (www.acconeer.com).

Summary of the Rights Issue

  • One (1) existing share in the Company on the record date, 14 March 2025, entitles to three (3) subscription rights. Thirty-four (34) subscription rights entitle to subscription of one (1) new share.
  • The Rights Issue comprises a maximum of 5,484,249 new shares. Upon full subscription in the Rights Issue, Acconeer will receive approximately SEK 25 million before deduction of issue costs.
  • The subscription price in the Rights Issue is SEK 4.56 per share, which corresponds to the closing price of the Company's share on 13 February 2025.
  • The subscription period in the Rights Issue runs from and including 18 March 2025 up to and including 1 April 2025.
  • In order not to lose the value of the subscription rights, the holder must either sell the subscription rights received that are not intended to be utilized for subscription of shares no later than 27 March 2025, or exercise the received subscription rights and subscribe for new shares no later than 1 April 2025.
  • The Company intends to use the proceeds from the Rights Issue to finance: (i) mainly the finalisation of the next generation radar sensor, A2, (ii) the commercialisation of A2 in new markets, development in new applications outside the automotive industry and (iiii) efforts with the aim of increasing sales and other business purposes.
  • Prior to the Rights Issue, the Company has received subscription undertakings totalling approximately SEK 4.28 million, corresponding to approximately 17.12 per cent of the Rights Issue. In addition, the Company has received free of charge bottom guarantee undertakings amounting to approximately SEK 2.0 million, corresponding to approximately 8 per cent of the Rights Issue. In addition, the Company has also received free of charge top guarantee undertakings totalling approximately SEK 18.72 million, corresponding to approximately 74.88 per cent of the Rights Issue. In total, 100 per cent of the Rights Issue is covered by free of charge subscription undertakings and free of charge bottom and top guarantee commitments. Neither the subscription undertakings nor the bottom or top guarantee commitments are secured by bank guarantees, blocked funds, pledges or similar arrangements.

For full terms and conditions of the Rights Issue and other information about the Company, please refer to the published Memorandum.

The Memorandum

The Memorandum has been prepared in connection with the forthcoming Rights Issue and has today, 13 March 2025, been made available in Swedish on the Company's website (www.acconeer.com).

The Memorandum is not a prospectus within the meaning of Regulation (EU) 2017/1129 (the ”Prospectus Regulation”) and has not been approved or reviewed by any regulatory authority in any jurisdiction. The Memorandum does not constitute a document in the form prescribed in Annex IX of the Prospectus Regulation.

Preliminary timetable for the Rights Issue

14 March 2025 Record date for entitlement to participate in the Rights Issue
18 March 2025 – 27 March 2025 Trading in subscription rights
18 March 2025 – 1 April 2025 Subscription period
18 March 2025 – 22 April 2025 Trading in paid subscribed shares (BTA)
3 April 2025 Estimated date of announcement of the outcome of the Rights Issue

Advisors

Moll Wendén Advokatbyrå AB is legal advisor to Acconeer AB in connection with the Rights Issue and Eminova Fondkommission AB is acting as issuing agent in connection with the Rights Issue.

Bulletin from the extraordinary general meeting of Acconeer AB (publ) on 6 March 2025

By

Acconeer AB (publ) held an extraordinary general meeting on 6 March 2025. At the meeting, the following main resolutions were made.

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

Resolution regarding the Board's proposal for a resolution on a directed share issue

The extraordinary general meeting resolved, in accordance with the Board of Directors' proposal, on a directed share issue consisting of a maximum of 5,482,456 shares, entailing an increase in the share capital of a maximum of SEK 274,122.8.

The right to subscribe for shares shall only, with deviation from the shareholders' preferential rights, be granted to Alps Alpine Co. Ltd. with a total 5,482,456 number of shares. The subscription price has, after arm's length negotiations between the company and Alps Alpine, been set at SEK 4.56 per share, which corresponds to the closing price of the company's share on 13 February 2025. Subscription for the newly issued shares shall be made on a separate subscription list no later than 31 March 2025. The Board of Directors has the right to extend the subscription period and the time for payment.

Resolution regarding the Board of Directors' proposal for a resolution on a share issue with preferential rights for the company's existing shareholders

The Extraordinary General Meeting resolved, in accordance with the Board of Directors' proposal, to issue a maximum of 5,484,249 new shares, increasing the share capital by a maximum of SEK 274,212.45.

The right to subscribe for the new shares shall be granted with preferential rights to the shareholders in proportion to the number of shares they already own, whereby one (1) existing share shall entitle to three (3) subscription rights and thirty-four (34) subscription rights shall entitle to subscription of one (1) new share. The subscription price shall be SEK 4.56 per share. The subscription period runs from 18 March 2025 to 1 April 2025. The Board of Directors has the right to extend the subscription and payment period.
__________

For more detailed information on the content of the resolutions, please refer to the press release published on 14 February 2025 and the full notice of the extraordinary general meeting. The notice of the extraordinary general meeting and the complete proposals regarding the resolutions of the extraordinary general meeting are available on the Company's website, www.acconeer.com.

Notice of Extraordinary General Meeting 2025 in Acconeer AB (publ)

By

Acconeer AB (publ), org.nr 556872-7654, (the “Company”) will hold an extraordinary general meeting on 6 March 2025 at 13.00, at the Company's office at Västra Varvsgatan 19, 211 77 Malmö.

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

Notification etc.
Anyone wishing to participate at the meeting shall:

  1. Be listed as a shareholder in the share register maintained by Euroclear Sweden AB as of the record date, which is 26 February 2025, and
  2. Give notice of the intent to participate at the meeting no later than 28 February 2025. Registration is made by post to Acconeer AB, att: Jenny Olsson, Västra Varvsgatan 19, 211 77 Malmö, or by e-mail, info@acconeer.com.

The notification shall state full name, personal or corporate identity number, shareholding, address, daytime telephone number and, where applicable, details of deputies, representatives and assistants. The number of advisors may not exceed two (2). The notification should, where applicable, be accompanied by powers of attorney, registration certificates and other documents of authority.

In order to be entitled to participate at the meeting, a shareholder whose shares are registered in the name of a nominee, through a bank or other nominee, must, in addition to giving notice of attendance at the meeting, register the shares in its own name with Euroclear Sweden AB so that the shareholder is entered in the share register as of 26 February 2025. Such registration may be temporary (so-called voting rights registration) and is requested from the nominee in accordance with the nominee's routines in such time in advance as the nominee determines. Voting rights registrations made no later than the second business day after 26 February 2025 will be taken into account in the preparation of the share register.

Proxies
If a shareholder is to be represented by a proxy, the proxy must bring a written, dated power of attorney signed by the shareholder to the meeting. The power of attorney may not be older than one (1) year, unless a longer period of validity (however, no longer than five (5) years) has been specified in the proxy. If the power of attorney is issued by a legal entity, the proxy must also bring the current registration certificate or equivalent authorisation document for the legal entity. To facilitate registration, a copy of the power of attorney and other authorisation documents should be attached to the notification to attend the meeting. A template proxy form will be available on the Company's website, www.acconeer.com, and at the Company's head office and will be sent by post to shareholders who contact the Company and state their address.

Proposed agenda

  1. Opening of the meeting.
  2. Election of chairman of the meeting.
  3. Election of one or two persons who shall approve the minutes of the meeting.
  4. Preparation and approval of the voting list.
  5. Approval of the agenda.
  6. Determination of whether the meeting has been duly convened.
  7. Resolution regarding the Board's proposal for a resolution on a directed share issue.
  8. Resolution regarding the Board of Directors' proposal for a resolution on a share issue with preferential rights for the company's existing shareholders.
  9. Closing of the meeting.

Item 2 – Election of chairman of the meeting
The Board of Directors has proposed that Henric Stråth or, in his absence, the person designated by the Board of Directors, be elected chairman of the meeting.

Item 7 – Resolution regarding the Board's proposal for a directed share issue
The Board of Directors of Acconeer AB proposes that the extraordinary general meeting resolves on a directed share issue of a maximum of 5,482,456 shares, entailing an increase in the share capital of a maximum of SEK 274,122.8.

The decision shall otherwise be subject to the following conditions.

  1. The right to subscribe for the new shares shall only, with deviation from the shareholders' preferential rights, be granted to the existing and strategically important shareholder Alps Alpine Co., Ltd. with a total 5,482,456 number of shares. The reasons for the deviation from the shareholders' preferential rights and that the directed share issue is directed to an existing shareholder are as follows. Prior to the decision to propose the directed share issue, the Board of Directors has carefully investigated and considered alternative financing options, including raising capital solely through a rights issue. However, after an overall assessment and careful consideration, the Board of Directors considers that a share issue carried out with deviation from the shareholders' preferential rights in combination with a rights issue is a more favourable alternative for the Company and the Company's shareholders than an isolated rights issue and that it is objectively in the interest of both the Company and its shareholders to carry out the directed share issue. The Board of Directors has considered, inter alia, the following.
    1. Alps Alpine is an existing shareholder in the company and an important partner. The reason why the directed share issue is directed to an existing shareholder in the company is that it has expressed and shown a long-term interest in and commitment to the company, which, according to the Board of Directors, creates security and stability for both the company and its shareholders. Alps Alpine is a strategically important investor, and without Alps Alpine it would not have been possible for the company to secure the financing for the A2 project. At the same time, other shareholders are given the opportunity to subscribe for shares on the same terms through the rights issue.
    2. The Company is in an important phase and has a need for financing to secure its long-term operations. A more extensive and isolated rights issue would require significantly more time and resources to implement and also entail a higher risk of negative impact on the share price, especially in light of the current volatile and challenging market conditions. From a shareholder perspective, an isolated rights issue thus entails a risk of a negative effect on the share price compared to a directed share issue in combination with a rights issue.

In light of the above, the Board of Directors' overall assessment is that the reasons for carrying out a directed share issue in combination with a rights issue outweigh the reasons for carrying out a more extensive isolated rights issue, and that the directed share issue to Alps Alpine is therefore in the interest of both the company and all its shareholders.

  1. Prior to the decision on the directed share issue, the Board of Directors has emphasised that the subscription price shall be on market terms in relation to the current share price. The subscription price has, after arm's length negotiations between the company and Alps Alpine, been set at SEK 4.56 per share, which corresponds to the closing price of the company's share on 13 February 2025. In light of this, the Board of Directors makes the assessment that the subscription price is on market terms and reflects the demand for the company's shares. The share premium shall be added to the unrestricted share premium reserve.
  2. Subscription of the newly issued shares shall be made on a separate subscription list no later than 31 March 2025. Oversubscription is not possible. Payment for the subscribed shares shall be made no later than 31 March 2025. The Board of Directors has the right to extend the subscription period and the time for payment.
  3. The new shares shall entitle to dividends as of the record date for the dividend decided immediately after the new shares have been registered with the Swedish Companies Registration Office and entered in the share register maintained by Euroclear Sweden AB.

The Board of Directors also proposes that the Board of Directors, or the person appointed by the Board of Directors, shall be entitled to make the minor changes to the resolution of the extraordinary general meeting that may be required in connection with registration with the Swedish Companies Registration Office, Euroclear Sweden AB or for other administrative reasons.

A resolution in accordance with this proposal shall only be valid where supported by not less than two-thirds of both votes cast and the shares represented at the extraordinary general meeting.

Item 8 – Resolution regarding the Board of Directors' proposal for a share issue with preferential rights for existing shareholders
The Board of Directors of Acconeer AB proposes that the extraordinary general meeting resolves on a rights issue of a maximum of 5,484,249 shares, entailing an increase in the share capital of a maximum of SEK 274,212.45.

The decision shall otherwise be subject to the following conditions.

  1. The right to subscribe for the new shares shall be granted with preferential rights to the shareholders in proportion to the number of shares they already own, whereby 1 existing share shall entitle to 3 subscription rights and 34 subscription rights shall entitle to subscription of 1 new share.
  2. The record date for determining which shareholders are entitled to subscribe for new shares with preferential rights (i.e. to receive subscription rights) shall be 14 March 2025.
  3. The subscription price shall be SEK 4.56 per share. The share premium shall be added to the unrestricted share premium reserve.
  4. Subscription of shares with preferential rights (i.e. with subscription rights) shall be made by simultaneous cash payment during the period from 18 March 2025 up to and including 1 April 2025. The Board of Directors has the right to extend the subscription and payment period
  5. Subscription of shares without preferential rights (i.e. without subscription rights) shall be made on a special subscription list during the period from 18 March 2025 up to and including 1 April 2025, or, with respect to subscription by any underwriters in accordance with item 6 below, no later than three (3) banking days thereafter. Payment for shares subscribed for without preferential rights (i.e. without subscription rights) shall be made in cash in accordance with the instructions on the contract note, however, no later than three (3) banking days from the dispatch of the contract note. The Board of Directors is entitled to extend the subscription and payment period.
  6. In the event that all shares are not subscribed for with subscription rights, the Board of Directors shall, within the limit of the maximum amount of the rights issue, decide on the allotment of shares subscribed for without subscription rights, whereby allotment shall be made as follows.
    1. Firstly, allotment shall be made to those who have subscribed for shares with subscription rights (regardless of whether they were shareholders on the record date or not) and who have expressed an interest in subscribing for shares without subscription rights and, in the event that allotment to these cannot be made in full, allotment shall be made pro rata in relation to the number of subscription rights that each of those who have expressed an interest in subscribing for shares without subscription rights have exercised for subscription of shares.
    2. Secondly, allotment shall be made to others who have subscribed for shares in the rights issue without subscription rights and, in the event that allotment to these cannot be made in full, allotment shall be made pro rata in relation to the total number of shares for which the subscriber has applied for subscription.
    3. Thirdly, allotment shall be made to those who have provided guarantee commitments regarding subscription of shares, in proportion to such guarantee commitments. If allotment at any stage according to the above cannot be made pro rata, allotment shall be made by drawing lots.
  7. The new shares entitle to dividends for the first time on the record date for dividends that occurs immediately after the new shares are entered in the share register maintained by Euroclear Sweden AB.

The Board of Directors also proposes that the Board of Directors, or the person appointed by the Board of Directors, shall be entitled to make the minor changes to the resolution of the extraordinary general meeting that may be required in connection with registration with the Swedish Companies Registration Office, Euroclear Sweden AB or for other administrative reasons.

Documentation
The complete proposals for resolutions and other documents to be provided prior to the extraordinary general meeting in accordance with the Swedish Companies Act will be made available at the Company and on the Company's website, www.acconeer.com, at least two weeks prior to the date of the extraordinary general meeting and will be sent free of charge to shareholders who so request and provide their postal address. In other respects, the board of directors' complete proposals for resolutions are set out in the notice.

Information at the extraordinary general meeting
The Board of Directors and the managing director shall, if any shareholder so requests and the Board of Directors considers that it can be done without material harm to the Company, provide information on circumstances that may affect the assessment of an item on the agenda.

Shareholders who wish to submit questions in advance may do so by mail to Jenny Olsson with the address Acconeer AB, Att: “Extraordinary General Meeting”, Västra Varvsgatan 19, 211 77 Malmö or by e-mail to info@acconeer.com. Submitted questions should include the shareholder's name including the shareholder's personal or organisation number. It is also recommended that submitted questions include the shareholder's postal address, e-mail address and telephone number.

Number of shares and votes in the Company
The total number of shares and votes in the Company as of the date of this notice amounts to 62,154,827.

Processing of personal data
For information on how your personal data is processed, please refer to the privacy policy available on the Euroclear website
https://www.euroclear.com/dam/ESw/Legal/ES_PUA_Privacy_notice_bolagsstammor.pdf.

____________

Malmö in February 2025
Acconeer AB
The Board of Directors

Acconeer updates organization to support new go-to-market strategy

By

To accelerate sales, Acconeer adopted a new go-to-market strategy with a clear focus on winning larger customers in specific growing volume markets. The go-to-market strategy was introduced in the Q3 interim report. Today we are taking the next step by updating the organization to reflect the new strategy.

The regional sales organization is strengthened in our most important markets. To ensure focus and bandwidth the sales team is divided into Sales Asia headed by Ted Hansson and Sales Europe, Americas & Australia headed by Magnus Gerward.

The Product organization is enhanced to support the focus markets, with clear responsibility for both the technical and commercial offering in these markets. This function is led by Mikael Egard.

The R&D organization will sharpen its focus on execution and is led by Karin Alfvén. Karin has been with the company since 2018 and previously held the position Head of Software Development.

In addition, Per Odénius is appointed Head of Operations, taking over from Lennart Moberg who will gradually ramp down for retirement. Per has been at Acconeer since 2015, most recently as Head of ASIC Development and R&D Program Manager.

CEO Ted Hansson comments: “The new organization creates clarity and focus to execute the new go-to-market strategy. I am confident that we now have the key ingredients; strategy, products, and organization to accelerate our growth.”

The complete management team will be found at Acconeer’s website.

Bulletin from the extraordinary general meeting of Acconeer AB on 31 October 2024

By

Acconeer AB (the “Company”) held an extraordinary general meeting on 31 October 2024. At the meeting, the following resolutions were made.

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

Warrant-based incentive programme for the Company’s CEO through a directed issue of warrants
The extraordinary general meeting resolved, in accordance with the board of directors’ proposal, on the warrant-based incentive program Warrant Program 2024/2027 by issuance of warrants of series 2024/2027 to Ted Hansson, the Company’s CEO.

No more than 350,000 warrants shall be issued to the CEO. Subscription of the warrants shall be made no later than 19 November 2024, or the later date resolved by the board of directors. Payment of the warrants shall be made no later than one week after subscription, or the later date resolved by the board of directors. The CEO shall pay a cash consideration amounting to the market value of the warrants at the time of subscription, which shall be determined by Optionspartner AB, or another independent valuation institute, using the Black & Scholes valuation model. According to a preliminary valuation, the market value of the warrants corresponds to approximately SEK 2.01 per warrant. Subscription of shares under the warrants may take place during the period from and including 20 November 2027 up to and including 31 December 2027. The premium per share shall be transferred to the free share premium reserve (Sw. fria överkursfonden). The subscription price per share shall correspond to 150 per cent of the volume-weighted average price according to Nasdaq First North Growth Market’s official curriculum list for shares in the Company during the period of ten (10) trading days ending on 31 October 2024, however, the subscription price per share shall never be less than the quota value of the share. The maximum dilution effect of the program is approximately 0.56 per cent.

________________

For more detailed information regarding the content of the resolutions, please refer to the press release published on 30 September 2024 and the complete notice of the extraordinary general meeting. The notice of the general meeting and complete proposals regarding the resolutions of the extraordinary general meeting are available on the Company’s website, www.acconeer.com.

Notice of Extraordinary General Meeting 2024 in Acconeer AB (publ)

By

The Extraordinary General Meeting of Acconeer AB (publ), reg. no. 556872-7654, (the “Company”) will be held on 31 October 2024 at 15:00 at the Company's office at Västra Varvsgatan 19, in Malmö.

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

Notification etc.
Those who wish to participate in the extraordinary general meeting must:

  1. be listed as a shareholder in the presentation of the share register prepared by Euroclear Sweden AB concerning the circumstances as per the record date of 23 October 2024; and
  2. give notice of intent to participate no later than 25 October 2024. Notification shall be made either in writing to Acconeer AB, att: Jenny Olsson, Västra Varvsgatan 19, SE-211 77 Malmö, or by email, info@acconeer.com.

The notice shall include full name, personal identification number or corporate registration number, address and daytime telephone number and, where appropriate, information about representative, proxy and assistants. The number of assistants may not be more than two (2). The notification should, where appropriate, be accompanied by proxies, registration certificates and other documents of authority.

In order to be entitled to participate in the meeting, a shareholder whose shares are registered in the name of a nominee must, in addition to giving notice of participation in the meeting, register its shares in its own name so that the shareholder is listed in the share register as of the record date of 23 October 2024. Such re-registration may be temporary (so-called voting rights registration), and a request for such voting rights registration shall be made to the nominee, in accordance with the nominee’s routines, at such time in advance as decided by the nominee. Voting rights registration that has been made by the nominee no later than the second banking day after 23 October 2024, will be taken into account in the presentation of the share register.

Proxies etc.
If a shareholder is to vote through a proxy, a written, dated and signed proxy by the shareholder must be provided at the general meeting. The proxy may not be older than one (1) year, unless longer validity (maximum of five (5) years) is stated in the proxy. If the proxy is issued by a legal entity, the current registration certificate or equivalent authorisation document for the legal entity must also be provided. To facilitate an easier passing, a copy of the proxy and other documents of authority should be enclosed with the registration for the general meeting. Proxy forms will be kept available on the Company’s website, www.acconeer.com, and at the Company’s head office and will be sent by post to shareholders who contact the Company and state their address.

Proposed agenda

  1. Opening of the meeting.
  2. Election of chairman of the meeting.
  3. Election of one or two persons to approve the minutes.
  4. Preparation and approval of the voting list.
  5. Approval of agenda.
  6. Determination as to whether the meeting has been duly convened.
  7. Resolution on the board of directors’ proposal for a resolution on an incentive programme for the CEO through a directed issue of warrants
  8. Closing of the meeting.

Item 7 – Resolution on the board of directors’ proposal for a resolution on an incentive programme for the CEO through a directed issue of warrants

The board of directors has proposed that the extraordinary general meeting resolves on a warrant-based incentive program for Ted Hansson, the CEO of the Company, in accordance with the conditions set out below (“Warrant Program 2024/2027”).

Background and motive
The purpose of the proposed program and the reasons for the deviation from the shareholders’ preferential rights are that the board of directors believes that a warrant program that allows the CEO to gain access to the Company’s value development promotes participation and accountability and brings increased motivation to promote favourable economic development for the Company.

In light of the above, the board of directors proposes that the meeting on an incentive programme for the Company's CEO through a directed issue of warrants of series 2024/2027, in accordance with below.

The Board of Directors' proposal for resolution on the implementation of Warrant Programme 2024/2027
For the implementation of Warrant Program 2024/2027, the board of directors proposes that the extraordinary general meeting resolves to issue a maximum of 350,000 warrants of series 2024/2027, implying an increase in the share capital upon full exercise with a maximum of SEK 17,500.

For the decision, the following conditions shall apply:

  1. No more than 350,000 warrants shall be issued.
  2. The right to subscribe for warrants shall, with deviation from the shareholders' preferential rights, be granted to Ted Hansson, the Company's CEO. The reason for the deviation from the shareholders' preferential rights is that the Warrant Programme 2024/2027 allows the CEO to gain access to the Company’s value development promotes participation and accountability and brings increased motivation to promote favourable economic development for the Company.
  3. Subscription of the warrants shall be made on a separate subscription list no later than 19 November 2024, the board of directors is entitled to extend the subscription period.
  4. The warrants shall be issued at the market value of the warrants at the time of subscription, which shall be determined by Optionspartner AB, or another independent valuation institute, using the Black & Scholes valuation model. According to a preliminary valuation, the market value of the warrants corresponds to approximately SEK 2.01 per warrant. The calculation is based on a share price of SEK 8.50, an exercise price of SEK 12.75 per share, a risk-free interest rate of 1.860 per cent and a volatility of 57 per cent, calculated according to the Black Scholes valuation model. With respect to restrictions on disposal of, and the illiquidity in the warrants, a so-called illiquidity discount of 15.0 per cent has been applied to the warrants’ value. The final price for the warrants will be established in connection with the subscription occasion to the CEO and will be based on market conditions prevailing at that time.
  5. Payment for the warrants shall be made in cash no later than one week after subscription, the board of directors is entitled to extend the payment period. Over-subscription cannot occur.
  6. Each warrant entitles the holder to subscribe for one (1) share in the Company.
  7. Subscription of shares under the warrants may take place during the period from 20 November 2027 up to and including 31 December 2027.
  8. The subscription price per share shall correspond to 150 per cent of the volume weighted average price according to Nasdaq First North Growth Market’s official curriculum list for shares in the Company during the period of ten (10) trading days ending on 31 October 2024, however the subscription price per share shall never be less than the quota value of the share. The subscription price shall be rounded to the nearest SEK 0.01, whereupon SEK 0.005 shall be rounded upwards. The premium per share shall be transferred to the free share premium reserve (Sw. fria överkursfonden).
  9. The shares subscribed for on the basis of the warrants shall entitle the holder to a distribution of profits for the first time on the first record date of dividends that occur after the subscription of shares has been exercised through the exercise of the warrants.
  10. Applicable re-calculation terms and other terms and conditions for the warrants can be found in “Terms and conditions for warrants series 2024/2027 for new subscription of shares in Acconeer AB (publ)”.
  11. The right to allotment of warrants in Warrant Program 2024/2027 assumes that (i) the CEO holds his position by the time of the allotment and not announced or been informed at that time that the employment is intended to be terminated, and (ii) that the CEO has entered into an agreement with the Company, according to which the Company, or the one the Company assigns, under certain circumstances has the right to repurchase the warrants from the participant if the participant’s employment ceases or if the participant wishes to transfer the warrants before they can be exercised for subscription of shares, in some cases at an amount corresponding to the lower of the Company's CEO's acquisition value of the warrants and the market value, in other cases at the market value.
  12. The Board of Directors, the CEO, or the person appointed by the Board of Directors or the CEO is authorised to make the minor amendments required for the registration of the resolution with the Swedish Companies Registration Office or Euroclear Sweden AB or due to other formal requirements.

Award criteria
No award criteria, beyond what is stated above, have been resolved upon to receive allocation in the incentive program. The board of directors believes that a program that includes the CEO provides the best conditions to achieve the board of directors’ objectives in implementing the programme.

Costs
Since the warrants are subscribed for at market value, the Company is of the opinion that there will be no social costs for the Company as a result of the issue. The costs will therefore mainly consist of limited costs for the implementation and administration of the warrants. Warrant Program 2024/2027 is not expected to entail any costs of significance to the Company. For this reason, no measures for hedging the program have been taken.

Dilution, previous incentive programs and effects on key ratios
As per the day of this proposal, there are 62,154,827 shares in the Company. Assuming that all warrants that can be issued under Warrant Program 2024/2027 are exercised for subscription of new shares, the number of shares and votes in the Company will increase by 350,000, which corresponds to a dilution of approximately 0.56 per cent of the number of shares and votes in Company. The dilution is expected to have a marginal impact on the Company’s key ratios.

The Company currently has six ongoing share-based incentive programs: Warrant Program 2021/2024:1, Warrant Program 2021/2024:2, Warrant Program 2022/2026, Warrant Program 2023/2026, Warrant Program 2023/2027 and Warrant Program 2024/2028. All share-related incentive programmes in the Company have been recalculated due to the rights issue resolved on 5 March 2024.

The annual general meeting resolved on 27 April 2021 to issue a maximum of 300,000 warrants to the Company’s wholly-owned subsidiary Acconeer Incentive AB, reg. no. 559156-2474 (the “Subsidiary”), which as of today holds 82,497 of these, through Warrant Program 2021/2024:1. The incentive program includes employees of the Company (but not fixed-term employees) including the CEO of the Company. The warrant holders have the right to, during the period from and including 15 May 2024 to and including 30 September 2024, call for subscription of 1.18 new shares in the Company at a subscription price of SEK 47.09.

The annual general meeting resolved on 27 April 2021 to issue a maximum of 300,000 warrants to the Subsidiary, which as of today holds 192,862 of these, through Warrant Program 2021/2024:2. The incentive program includes employees of the Company (but not fixed-term employees) including the CEO of the Company. The warrant holders have the right to, during the period from and including 15 November 2024 to and including 31 Mars 2025, call for subscription of 1.18 new shares in the Company at a subscription price of SEK 95.84.

The annual general meeting resolved on 26 April 2022 to issue a maximum of 300,000 warrants to the Subsidiary, which as of today holds 76,485 of these, through Warrant Program 2022/2026. The incentive program includes employees of the Company (but not fixed-term employees) including the CEO of the Company. The warrant holders have the right to, during the period from and including 3 December 2025 to and including 16 January 2026, call for subscription of 1.15 new shares in the Company at a subscription price of SEK 51.23.

The annual general meeting resolved on 26 April 2022 to issue a maximum of 300,000 warrants to the Subsidiary, which as of today holds 166,197 of these, through Warrant Program 2023/2026. The incentive program includes employees of the Company (but not fixed-term employees) including the CEO of the Company. The warrant holders have the right to, during the period from and including 25 March 2026 to and including 8 May 2026, call for subscription of 1.15 new shares in the Company at a subscription price of SEK 50.49.

The annual general meeting resolved on 27 April 2023 to issue a maximum of 500,000 warrants to the Subsidiary, which as of today holds 403,278 of these, through Warrant Program 2023/2027. The incentive program includes employees of the Company (but not fixed-term employees) including the CEO of the Company. The warrant holders have the right to, during the period from and including 24 March 2027 up to and including 5 May 2027, call for subscription of 1.15 new shares in the Company at a subscription price of SEK 9.88.

The annual general meeting resolved on 23 April 2024 to issue a maximum of 500,000 warrants to the Subsidiary, which as of today holds 500,000 of these, through Warrant Program 2024/2028. The incentive program includes the persons who are or will be employed by the Company (but not fixed-term employees) including the CEO of the Company. The warrant holders have the right to, during the period from and including 15 February 2028 up to and including 30 April 2028, call for subscription of a new share in the Company at a subscription price corresponding to 150 per cent of the volume weighted average price according to Nasdaq First North Growth Market’s official curriculum list for shares in the Company during the period of ten (10) trading days ending on 15 November 2024.

If (i) all outstanding warrants issued in connection with the ongoing incentive programs, including the warrants from Warrant Program 2024/2028 currently held by the Subsidiary, however, excluding the other warrants held by the Subsidiary, are exercised in full for subscription of shares, (ii) the general meeting resolves on the implementation of Warrant Program 2024/2027 in accordance with the proposal, and (iii) all warrants that can be issued in or in connection with Warrant Program 2024/2027 are exercised for subscription of shares, the number of shares and votes in the Company will increase by 1,755,222 which corresponds to a total dilution of approximately 2.75 per cent of the number of shares and votes in the Company.

The above estimates are subject to revaluations of the warrants under the usual translation terms contained in the full terms, but taking into account the recalculation due to the rights issue resolved by the Board of Directors by virtue of the authorisation on 5 March 2024. All dilution effects have been calculated as the number of additional shares in relation to the number of existing plus additional shares.

Preparation of the proposal
The proposal for resolution on the implementation of Warrant Program 2024/2027 has been prepared by the board of directors together with external advisors. Board members will not be allotted. The CEO has not participated in the preparation of the proposal.

Majority requirements
A valid resolution requires that the resolution is supported by shareholders with at least nine tenths (9/10) of both the votes cast and the shares represented at the meeting.

Available documents
The complete proposals and other documents that shall be made available prior to the general meeting pursuant to the Swedish Companies Act will be made available at the Company and at the Company’s website, www.acconeer.com, at least three weeks prior to the extraordinary general meeting. The documents will also be sent free of charge to shareholders who so request and provide their address to the Company. In other respects, the board of directors’ complete proposals for resolutions are stated in the notice.

Information at the extraordinary general meeting
Shareholders present at the Extraordinary General Meeting have the right to request information in accordance with Chapter 7, Section 32 of the Swedish Companies Act (2005:551).

Shareholders who wish to submit a question in advance can do so by mail to Jenny Olsson at the address Acconeer AB, Att: “EGM 2024” Västra Varvsgatan 19, SE-211 77 Malmö or by email to info@acconeer.com. Submissions should include the name of the shareholder including such shareholder’s personal or organisation number. It is also recommended that the submission includes the shareholder’s postal address, email address and telephone number.

Shares and votes in the Company
The total number of shares and votes in the Company amount to 62,154,827, as per the date of this notice. The Company does not hold any own shares.

Processing of personal data
For information on how your personal data is processed, the Company refers to the integrity policy available on Euroclear Sweden AB’s website https://www.euroclear.com/dam/ESw/Legal/Privacy%20notice%20BOSS%20-%20final%20220324.pdf.

____________

Malmö in September 2024
Acconeer AB
The Board of Directors

Bulletin from the annual general meeting of Acconeer AB on 23 April 2024

By

Acconeer AB (the “Company”) held its annual general meeting on 23 April 2024. At the annual general meeting, the following resolutions were made.

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail.

Adoption of the income statement and balance sheet
The annual general meeting resolved to adopt the board of directors’ proposal for the income statement and the balance sheet for the fiscal year of 2023.

Disposition of the Company’s profit or loss
The annual general meeting resolved, in accordance with the board of directors’ proposal, that no dividend is paid and that the Company’s funds available for distribution is carried forward.

Discharge from liability
The annual general meeting resolved to grant discharge from liability to all persons who have had the position of board member or CEO in the Company during 2023.

Election on the board of directors and auditor, and determination of fees
The annual general meeting resolved to re-elect Lars-Erik Wernersson, Git Sturesjö Adolfsson and Thomas Rex as members of the board, and to elect Henric Stråth as a new board member. Thomas Rex was re-elected as chairman of the board of directors.

The annual general meeting resolved that the fees to the board of directors, for the period until the next annual meeting, shall be paid out with a total of fourteen (14) price base amounts (Sw. prisbasbelopp), of which five (5) price base amounts to the chairman and three (3) price base amounts to each of the other members elected by the annual general meeting who are not employed by the Company.

The annual general meeting resolved to re-elect the registered audit company KPMG AB as the Company’s auditor until the end of the next annual general meeting. Fees to the auditor shall be paid according to approved invoice.

Directed issue of warrants and approval of transfer of warrants
The annual general meeting resolved, in accordance with the board of directors’ proposal, on the warrant-based incentive program Warrant Program 2024/2028 by (A) issuance of warrants of series 2024/2028 to the Company’s wholly-owned subsidiary and (B) approval of the transfer of warrants 2024/2028 from the subsidiary to individuals who are or will be employed by the Company (individuals employed for a fixed time period are excluded) including the CEO (“Employees”).

No more than 500,000 warrants shall be issued to the subsidiary with the right and obligation for the subsidiary to later transfer the warrants to the Employees. The warrants shall be transferred by the subsidiary on 22 November 2024, or on the later date decided by the board of directors, the transfer shall be made at market value at the respective transfer dates and warrants shall be allotted in accordance with the principles set forth in the board of directors’ proposal. Subscription of shares under the warrants may take place during the period from 15 February 2028 until 30 April 2028. The premium per share shall be transferred to the free share premium reserve (Sw. fria överkursfonden). The subscription price per share shall correspond to 150 per cent of the volume-weighted average price according to Nasdaq First North Growth Market’s official curriculum list for shares in the Company during the period of ten (10) trading days ending on 15 November 2024, however, the subscription price per share shall never be less than the quota value of the share. The maximum dilution effect of the program is approximately 1.84 per cent.

________________

For more detailed information regarding the content of the resolutions, please refer to the press release published on 12 March 2024 and the complete notice of the annual general meeting. The notice of the annual general meeting and complete proposals regarding the resolutions of the annual general meeting are available on the Company’s website, www.acconeer.com.

Acconeer announces final outcome in the company’s fully guaranteed rights issue

By

Acconeer AB (“Acconeer” or the “Company”) announces today the final outcome in the Company’s rights issue of shares of approximately SEK 149 million (the “Rights Issue”), which is fully covered through a combination of subscription undertakings and guarantee commitments. The subscription period in the Rights Issue ended on 28 March 2024. The final outcome shows that 28,372,000 shares, corresponding to approximately 79.9 percent of the offered shares, have been subscribed for with support of subscription rights. Additionally, applications for subscription of 5,893,311 shares without the support of subscription rights, corresponding to approximately 16.6 percent of the offered shares, have been submitted. Together, subscriptions with support of subscription rights and subscriptions without the support of subscription rights correspond to approximately 96.5 percent of the offered shares in the Rights Issue. Thus, guarantee commitments of 1,251,733 shares, corresponding to approximately 3.5 percent of the offered shares, will be utilised. The Rights Issue will provide the Company with approximately SEK 149 million before deduction of transaction costs.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO SECTION “IMPORTANT INFORMATION” BELOW.

The Rights Issue comprised 35,517,044 shares, of which 28,372,000 shares, corresponding to approximately 79.9 percent of the offered shares, have been subscribed for with support of subscription rights. Additionally, applications for subscription of 5,893,311 shares without support of subscription rights have been submitted, corresponding to approximately 16.6 percent of the offered shares. A total of 5,893,311 shares, corresponding to 16.6 percent of the offered shares, have been allotted to individuals who have applied to subscribe for shares without support of subscription rights. Together, subscriptions for shares with support of subscription rights and subscription for shares without support of subscription rights correspond to approximately 96.5 percent of the offered shares in the Rights Issue. Thus, guarantee commitments of 1,251,733 shares, corresponding to approximately 3.5 percent of the offered shares, will be utilised. As a result of the Rights Issue, Acconeer’s share capital will increase by 1,775,852.20 SEK to 3,107,741.35 SEK and the number of shares and votes will increase by 35,517,044 to 62,154,827.

The last day for trading in paid subscribed shares (BTA) is expected to be on 8 April 2024. The new shares subscribed for with support of subscription rights are expected to be registered with the Swedish Companies Registration Office around 5 April 2024 and the new shares are expected to start trading on Nasdaq First North Growth Market as of 12 April 2024. The new shares subscribed for without support of subscription rights are expected to be registered with the Swedish Companies Registration Office around 11 April 2024 and the new shares are expected to start trading on Nasdaq First North Growth Market as of 12 April 2024.

Lock-up undertakings
Prior to the Rights Issue, all board members and key executives in the Company have entered into lock-up undertakings, including commitments not to dispose of financial instruments in the Company, with certain exceptions. The lock-up undertakings expire 180 days after the announcement of the outcome of the Rights Issue.

Furthermore, the Company has undertaken in relation to Carnegie Investment Bank AB, with customary exceptions, not to issue additional shares or other share-related instruments for a period of 180 days after the announcement of the outcome of the Rights Issue.

Advisers
In conjunction with the Rights Issue, the Company has engaged Carnegie Investment Bank AB (publ) as Sole Global Coordinator and Bookrunner, and Advokatfirman Schjødt as legal advisor.